Glazer Capital LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

Glazer Capital LLC’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,683,687	Closed	-$100M	–	560
2026 Q1	$100M	Buy	+4,683,687	New	+$66M	2.13%	12

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glazer Capital LLC's DAWN Position: Q2 2026 in Review

Glazer Capital LLC sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 4,683,687 shares — an estimated $100M sold.

Glazer Capital LLC first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $100M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Glazer Capital LLC reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Glazer Capital LLC sold 4,683,687 Day One Biopharmaceuticals shares in Q2 2026, an estimated $100M.
Glazer Capital LLC first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Glazer Capital LLC's Day One Biopharmaceuticals position peaked at $100M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.